Capricor Therapeutics CAPR Investment & Other Income
Investment & Other Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterestAndDividend.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's investment & other income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Capricor Therapeutics's investment & other income?
- Capricor Therapeutics (CAPR) reported investment & other income of $2.9M in Q1 2026.
- How has Capricor Therapeutics's investment & other income changed year-over-year?
- Capricor Therapeutics's investment & other income increased by 298.1% year-over-year, from $729.54K to $2.9M.
- What is the long-term trend for Capricor Therapeutics's investment & other income?
- Over 4 years (2021 to 2025), Capricor Therapeutics's investment & other income has grown at a 223.0% compound annual growth rate (CAGR), from $57.46K to $6.26M.